These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21263007)

  • 1. Serious cardiovascular outcomes in diabetes: the role of hypoglycemia.
    Yakubovich N; Gerstein HC
    Circulation; 2011 Jan; 123(3):342-8. PubMed ID: 21263007
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
    Currie CJ; Johnson JA
    Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The risk of hypoglycemia in patients with pharmacologically treated diabetes mellitus: clinical analysis].
    Stepka M; Rogala H
    Pol Tyg Lek; 1988 Jan; 43(2):52-5. PubMed ID: 3387313
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of excess cardiovascular mortality in diabetes.
    Keen H; Ashton CE
    Postgrad Med J; 1989; 65 Suppl 1():S26-9. PubMed ID: 2695907
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensive glucose lowering treatment in type 2 diabetes.
    Preiss D; Ray KK
    BMJ; 2011 Jul; 343():d4243. PubMed ID: 21791496
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose-lowering therapy after myocardial infarction: more questions than answers.
    Radke PW; Schunkert H
    Eur Heart J; 2008 Jan; 29(2):141-3. PubMed ID: 18199566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus.
    van der Schaaf RJ; Henriques JP; Wiersma JJ; Koch KT; Baan J; Mulder KJ; Durrer JD; Tijssen JG; Piek JJ; de Winter RJ
    Heart; 2006 Jan; 92(1):117-8. PubMed ID: 15890764
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronary artery surgery in patients with diabetes mellitus].
    Lauruschkat AH; Ennker J
    Dtsch Med Wochenschr; 2002 Feb; 127(8):381-3. PubMed ID: 11859447
    [No Abstract]   [Full Text] [Related]  

  • 11. Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes.
    Barry HC
    Am Fam Physician; 2016 Sep; 94(5):386. PubMed ID: 27583428
    [No Abstract]   [Full Text] [Related]  

  • 12. Interplay of diabetes and coronary heart disease on cardiovascular mortality.
    Boccara F; Cohen A
    Heart; 2004 Dec; 90(12):1371-3. PubMed ID: 15547003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
    Leschke M
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underestimated risk for type 2 diabetic patients: danger due to hypoglycemia].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Apr; 152(17):12. PubMed ID: 20509251
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes mellitus and myocardial infarct--new answers and questions].
    Kaloianov KN
    Vutr Boles; 1999; 31(4):29-34. PubMed ID: 10989672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypoglycemia risk. Why elderly patients are especially at risk].
    Stiefelhagen P
    MMW Fortschr Med; 2002 May; 144(22):10. PubMed ID: 12116563
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarction.
    Moejko-Pastewka B; Tatoń J; Haczyński J; Strojek K; Ametov AS; Milicevic Z
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S354-7. PubMed ID: 14704868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease.
    Ragucci E; Zonszein J; Frishman WH
    Heart Dis; 2003; 5(1):18-33. PubMed ID: 12549986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.